Connect with us

General News

Trump Withdraws The US From The WHO’s Covax Program

Published

on

US leaves WHO's COVID-19 vaccine plan

When it comes to the deadly COVID-19 pandemic that swept the world this year, unity and focus are paramount. Nations across the world must join hands to promote self-quarantine and social distancing laws, and restrict travel. And the only cure to this pandemic is the development of a practical vaccine, according to the WHO. Once the masses receive successful inoculation, the coronavirus pandemic can come to an end. Said vaccine would therefore have to match several criteria. It must be cheap, easy to make and have minimal side effects.

However, the largest health group in the world, the WHO, now faces resistance from the USA. The United States have a history of funding and supporting international crisis relief plans, but now opposes the WHO’s ‘Covax’ initiative. The Covax initiative is essentially the WHO’s call to arms: numerous countries collaborating to develop a viable vaccine together. But the US, under the administration of President Donald Trump, has spurned the program.

The main reason the US withdrew from the plan was because of alleged Chinese influence

It’s no secret that the US and China long consider their relationship tenuous at best. Despite the latter being one of the biggest producers of goods, especially products that the US frequently imports, things aren’t secure. As both nations have different interpretations of government and economic rule, and both are hubs of scientific and financial growth, jealousy abounds. Furthermore, both nations accuse the other of illicit meddling, spying and other big claims.

Under the reign of President Trump, right wing political stances have returned in a big way. While domestically, racism and bigotry soar, the country’s international policies are not better. Fear-mongering against the Middle East, China and (to a lesser extent) Russia have led to limited contact. A new wave of sinophobia is here, which prompted the US to withdraw from the WHO last year. This was just because of China’s involvement in the organization.

Covax’s progress being hindered is a serious concern, and may delay the vaccine

The withdrawal of the US from the WHO was problematic enough. The nation was always a top contributor of the WHO, paying upwards of $450 million in funding at one point. Last year, the decision rattled the scientific and healthcare communities, just as the US’s withdrawal from the Paris Accords did.

The absence of American scientists an experts from the WHO’s panel is not a good sign. While many private syndicates world-wide seek to create a viable COVID-19 vaccine, there needs to be a coordinated effort. Even several Chinese companies are making good progress in developing a suitable product. Meanwhile, the Trump Administration claims it will have its own vaccine ready by November, though experts say this is unlikely.

Pointless nationalism like that of the US is a major obstacle for vaccine development

It is not a stretch to say that even outside of the pandemic, many countries despise each other. The urgent need of a vaccine has raised several legitimate theoretical concerns. What if only the rich can afford it? What if supply cannot match demand? And, what if a nation refuses to supply its enemy with vaccines? The last question is apt here, because often a nationalistic stance can be the downfall of all of human-kind. If Israel develops it, would it inoculate Palestinians? Would China be willing to forgive Trump’s oafish and reckless policies, and help the US?

Hence, it remains to be seen just what impact the US’s policies create. Until the day comes, only time will tell. Stay with us for the latest scoops on the future of the post-COVID world.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Cannabis

No More Firing Or Barring of Workers Or Applicants Over Cannabis Screening, Says Amazon

Published

on

No More Firing Or Barring of Workers Or Applicants Over Cannabis Screening, Says Amazon

Amazon has been in favor of legalizing and decriminalizing cannabis in all states. The company favors federally altering reforms to make new legislation for legalization and decriminalization of marijuana. It also supports altering employer-employee policy with respect to new legalization rules. 

 

Amazon reestablished its employment eligibility criteria for previous workers or job applicants. Previously, the company used to fire employees with positive cannabis screening results. The same used to happen with job applicants, they were considered ineligible to apply for any job. 

 

Moreover, in June 2021, Amazon changed its policy and ended pre-employment cannabis screening for many applicants for various job posts.

 

Amazon And Cannabis-Employment Policy

 

Amazon is one of the largest e-commerce platforms with millions of clients and workers. The company is planning to further relax its cannabis screening policies to support federal legalization legislation.

ALSO READ: Best CBD For Terriers Dogs

The previous cannabis employment policy contains that individuals, former workers, and applicants, that use cannabis will be fired or will not be selected for any post. However, things change over the last 18 months. Now people with a history of using marijuana and those with positive screening results can continue their jobs and office work freely irrespective of pot usage.

 

The pre-employment test and screening processing adversely affected many people, especially people of color. Minority communities are most affected. According to Beth Galetti, people of color suffer from these policies, and the team of employees and employers in Amazon consider such behavior unacceptable. The people of color had to go through inequitable treatment.

 

Changes In Employment Policy

 

In June this year, the company announced that it no longer screens its workers for cannabis. However, the company’s new employment policy requires employees and applicants for the Department of Transport to pass through a marijuana screening test. Employees such as heavy equipment operators and truck drivers have to clear marijuana screening before beginning their job and can be asked to perform screening whenever necessary.

 

Hiring cannabis consumers was a positive change in the employment policy made by Amazon. Hopefully, many other companies will follow the example and bring an alteration to society. 

 

Yet employees will go through regular tests, including tests for alcohol and other drugs. The company can ask employees to undergo a drug test after any incident. 

 

Why Allow Cannabis users To Apply And DO Jobs?

 

Amazon observed that many states are legalizing and decriminalizing marijuana. After learning the change in perspective of the public and legislators, the company also decided to relax its cannabis standards.

ALSO READ: New York Cannabis Industry And Park Strategies

According to Beth Galetti, allowing former cannabis users to apply for a job will lure more applicants in a tight labor market. It will also reduce the suffering of people of color somehow.

 

Amazon is looking for field experts and enthusiastic employees. According to Galetti, they have discovered that eliminating pre-employment testing for cannabis permits the company to expand its applicant pool. 

 

According to Bloomberg, Amazon encourages its delivery firms to advertise that they do not require cannabis screening. Also, the company is lobbying the federal government to legalize pot. Amazon supports the Marijuana Opportunity Reinvestment and Expungement Act. The objective of this act is to decriminalize cannabis at the federal level. One of the aims is to expunge criminal records. According to the Act, this will bring investments to these communities. 

 

Amazon also recently endorsed a similar bill on Tuesday called the Cannabis Administration and Opportunity Act. The company is urging congress to expunge federal nonviolent marijuana crimes and legalize pot federally. 

Originally Covered On: CNBC

Continue Reading

Cannabis

Edible Cannabis Items Might Contain Dangerous Delta-8 THC Substances

Published

on

Edible Cannabis Items Might Contain Dangerous Substances

Cannabis-infused edibles are known as edible marijuana products. There is a high possibility that these items contain Delta-8 THC which leads to increased side effects and damage to consumers’ health.

 

A health advisory committee will discover more about the subject. An official member of the federal Centers for Disease Control and Prevention is joining hands with the Food and Drug Administration to investigate the presence of delt-8 THC in cannabis-infused products.

 

There has been an increase in the demand and supply of marijuana-containing items during the coronavirus pandemic situation. Many such products contain delta-8-tetrahydrocannabinol (THC) and (cannabidiol) CBD. But insufficient labeling of items puts consumers in jeopardy. People unknowingly consume THC and CBD, leading to intoxication. 

 

Delta-8 THC In Cannabis Edibles Intoxication 

 

Intoxication disturbs body functioning, and people, after consuming edible products of pot may develop delta-8 THC toxicity. They experience lethargy, slurred speech, uncoordinated movements, and low blood pressure.

ALSO READ: Former Hudson Valley Prison Transforming Into A New Cannabis Facility

People also develop decreased psychomotor activity, increased heart rate progression to slowed heart rate, and difficulty breathing. In some conditions, some individuals experience sedation and fall into a coma. 

 

According to the advisory, the health impacts of delta-8 THC are not available, due to a lack of research. It is not well-understood whether it is as damaging as delta-9 THC or is different from it. However, it is known that delta-8 THC is a psychoactive compound capable of causing similar impairing effects as delta-9. 

 

Presence of Isomeric Compounds In Cannabis

 

Marijuana plants contain multiple isomers that exist in various parts of the plant. Some components have beneficial effects, and others have side effects. Delta-8 THC and delta-9 THC are present in the cannabis plant naturally but only in small quantities. 

 

Delta-8 THC is present with 50 percent to 75 percent of the psychoactive punch as delta-9 THC. Various isomers of THC, including delta-8, and delta-9 come from the synthetic conversion of CBD. Cannabidiol is not psychoactive, but THC is. 

 

Delta-8 THC Containing Products Increasing In Marketplaces

 

The number of delta-8 THC-containing products is increasing in the marketplaces of both hemp and marijuana both. In some areas, sales of such items occur legally by following territorial, state, or tribal laws. According to the official CDC Health Advisory, most states and territories allow full or restricted marijuana marketplaces. In these states, hemp and its derived CBD items are undergoing sales process lawfully. 

 

The advisory also says that delta-8 THC-containing cannabis products are purchasable online. Moreover, marketing of these products occurs under the names “weed light” or “diet weed”. 

 

Many marijuana marketplaces contain several delta-8 THC-containing products, but the label mentions delta-9 THC only. The THC content in these products increases. Due to inaccurate labeling, consumers of cannabis edibles with delta-8 THC experience unexpected or increased THC intoxication.

 

CDC Reports And Delta-8 THC Containing Products

 

There is a large variety of delta-8 THC-containing marijuana products in the market. Vapes, smokeable marijuana sprayed with delta-8 THC extract, tinctures, and chocolates containing THC are in abundance in the market. Delta-8 THC contains distillates, gummies, infused beverages, and many more cannabis edible items that are purchasable from marketplaces.

ALSO READ: Cannabis Industry Welcomes Black Americans, But For Many Of Them Entry Price Is Steep

According to the advisory, there is no testing procedure available to determine the presence of delta-8 THC in marijuana edibles. Testing methods are in the development process and require research and time. Moreover, testing to determine the presence of contaminants does not occur due to a lack of advanced testing procedures. These contaminants like heavy metals, solvents, insecticides, or pesticides may cause adverse reactions in consumers. 

 

The CDC report indicates an increase in delta-8 THC intoxication cases. CDC gathers information from emergency departments participating in its National Syndrome Surveillance Program. 

 

Thirty-nine percent of the patients admitted to the emergency department due to delta-8 intoxication are younger than eighteen years of age. Eighteen percent of those taken to the emergency department require hospitalization to recover from in-toxicity of delta-8 THC.

Originally covered on: foodsafetynews

Continue Reading

Cannabis

Former Hudson Valley Prison Transforming Into A New Cannabis Facility

Published

on

Former Hudson Valley Prison Transforming Into A New Cannabis Facility

Growing and cultivating cannabis in Warwick is the new trend in the locality. The town is undergoing debating sessions on whether to permit marijuana dispensaries or not. 

 

The existing marijuana industry is looking for new market potentials and trying to get into new markets. Facilitating people legally by providing them high-quality weed products is the goal of many big marijuana companies.  

Cannabis firms are keeping a keen watch over states marijuana policies and legalization trends to expand their businesses. Local businesses are also interested in becoming a part of the quickly growing marijuana industry. 

 

The Green Thumb Industries are setting new marijuana cultivation and production unit at a former prison Hudson Valley in Warwick. The CEO of the Green Thumb Industries is Ben Kovler. On Thursday, September 9, Ben announced that the firm is beginning a production facility in that region. The company already has many cultivation and production facilities in fourteen states. The opening of a cannabis production and cultivation facility in Warwick will be beneficial for locals. Doing so will generate 100 permanent jobs at a minimum. 

 

The Warwick prison once holds 1000 inmates and it was a medium-security prison. By 2023 it will completely operate as a marijuana cultivation site. 

 

Cultivation Of Cannabis And Its Legalization

 

Multiple states including New York legalize marijuana for recreational purposes. Marijuana industrialists are moving towards new marketplaces to expand their business. Green Thumb Industries is a Chicago-based cannabis operator. 

ALSO READ: New York Cannabis Industry And Park Strategies

They began construction of their cultivation and production facility on Thursday at the former Mid-Orange Correctional Facility site. The site is located on John Hicks Drive, joining Citiva Medical. Moreover, Citiva Medical has already begun its greenhouse and processing unit for cannabis cultivation and processing.

 

The legislators of New York approves of the marijuana legalization bill this year. Adult use of weed items by individuals, above or equivalent to 21 years of age becomes legal. The approval of the legislation encourages manufacturers to start developing sites for cannabis cultivation and production in the area.

 

Employment And Cannabis

 

According to Ben Kovler, marijuana, employment, and the economy is a full-circle moment. Cresco Labs also propose the development of a marijuana cultivation facility. This facility will provide 300 to 400 jobs in 2022 once construction begins. 

 

The expansion of cannabis markets and industries increases the chances of individuals getting jobs. The number of employed individuals gets better with an increase in job opportunities. People begin to make a living as more marijuana firms develop and progress.

 

Kovler does not like that there is still a prison that has imprisoned inmates for marijuana activities. Individuals in the past for cultivating, possessing, or getting involved in marijuana activities were put into jail and are still there. There is also a need to do something about them and resolve the matters as now the nation legalizes cannabis.

 

More About Green Thumb Industries and Their Marijuana Services

 

The Green Thumb Industries has sixteen cultivation and processing facilities and sixty-four retail locations in fourteen different states. According to Ben Kovler, Green Thumb is one of the ten registered organizations permissible to participate in the medical cannabis program. 

 

The firm is investing $150 million to remodel the Orange County site. The construction of a cultivation facility will generate at least a hundred construction jobs. More than 100 permanent jobs creation will occur once they are ready to operate.

ALSO READ: Ban On Cannabis Marketing Via Billboards In Michigan

There is a need for supervisors, operational roles, managers, and general managers in the cannabis processing facility. According to Ben Kovler, it is time for individuals to learn skills with passion, and the firm can create a long-lasting career for them.

 

Recreational cannabis dispensaries will likely open by 2023. At the same time, Green Thumb products will be ready to make a launch on the market. Things are slowly progressing towards a better future for the cannabis industry. 

Originally covered on: timesunion

Continue Reading

Trending

error: Content is protected !!